759,000 children with asthma endure gaps in insurance every yearJanuary 16, 2008Chronic condition requires ongoing treatment to avoid hospitalizations Every year, 759,000 children with asthma may be at risk of a major asthma attack while they have no health insurance. About 30 percent of those families earn more than 200 percent of the federal poverty level, putting them above the threshold for the state children's health insurance program in most states. "Too many children with this chronic condition are without insurance at some point during the year," said Jill Halterman, M.D., M.P.H., associate professor of Pediatrics at the University of Rochester and author of the study that appears in Ambulatory Pediatrics today. "These children need to have ongoing treatment from a primary care provider to avoid serious health complications. Without that, they are at increased risk for ongoing symptoms and even hospitalization." About 13 percent of children with asthma were without insurance at some point during the year. That includes 2 percent - or 114,000 children - who were uninsured for the entire year. Those same children were 14 times more likely to have had an unmet need for medication than children with private insurance. Even those who gained insurance by the time of the survey were six times more likely to have missed out on needed medication. The study, which is an analysis of data from the National Survey of Children's Health (conducted by the Center for Disease Control's National Center for Health Statistics between January 2003 and July 2004), also showed that many children with asthma were not seeing a regular physician often enough. Almost one-third of parents of uninsured children said they had no personal primary care doctor for their child. More than one-third of parents of children who had lost insurance and about half of parents of children with no insurance for a full year said their child hadn't seen a personal doctor for preventive care in the past year. "Healthy children should see a physician for preventive care at least once a year. Children with asthma need even more consistent care to prevent asthma attacks and other related illnesses. No year should go by for a child with asthma without at least one, if not more, visits to their regular physician to update treatment plans and address ongoing health issues," Halterman said. "We, as physicians, have very clear guidelines about how to effectively manage a child's asthma symptoms, but we can't help these children if we don't see them." No differences were found between children with private and public insurance, when it came to unmet needs, discontinuity in care or poor access. This suggests that consistency of coverage for children with asthma is more important than the source of insurance. Recent studies conducted by the University of Rochester Medical Center have shown that providing insurance to children with asthma through the State Child Health Insurance Program (SCHIP) reduces their unmet needs and reduces racial disparities in access to care. "No child, especially one with a chronic health condition such as asthma, should go without health care because of situations over which they have no control. Insurance costs a lot to buy, and many people can't get approved because of past health problems. There will always be families who earn too much to qualify for private insurance yet too little to afford private insurance. It is hard to see children suffer with conditions like asthma, where we know what to do and we know that it helps - just because they cannot get health insurance." said Laura Shone, Ph.D., M.P.H., an assistant professor of pediatrics at the University of Rochester Medical Center and an author of this study and several others on children's access to care. University of Rochester Medical Center |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Exposures to metals and diesel emissions in air linked to respiratory symptoms in children Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||